Share on

Middle East & Africa RNA Analysis Market Research Report - Segmented By End User, Type, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, Growth, Forecasts | 2022 to 2027

Published: January, 2022
ID: 4388
Pages: 131
Formats: report pdf report excel report power bi report ppt

Middle East & Africa RNA Analysis Market Size & Growth (2022 to 2027)

As Per the Report, the Middle East & Africa RNA Analysis Market is valued at USD 0.09 Billion in 2022 and is predicted to grow at a CAGR of 11.06%, to reach USD 0.15 Billion by 2027 during the forecast period 2022 to 2027.

The growing need for customized medicine and the increasing use of RNA sequencing in the transcriptomics industry is projected to drive the MEA RNA Sequencing Analysis market.

In addition, the market is expected to grow as demand for tailored treatment, and RNA sequencing applications in transcriptomics grows. Therefore, the RNA analysis market is predicted to grow significantly over the forecast period, owing to rapid advancements in the transcriptomics field. Furthermore, the increased interest in outsourcing services, as well as the expanding focus on biomarker research and toxic genomic, is projected to generate significant prospective chances for MEA RNA analysis market participants.

Over the projection period, the astonishing increase in private and non-private investments may provide an incredible potential for the RNA analysis market. In addition, the growing interest in outsourcing services and a greater focus on biomarker development and toxic genomic research are projected to present significant growth opportunities for global market participants. 

The rapid expansion of the RNA analysis market is enticed by the rising frequencies of genetic alterations in genetic variations and carcinogens. Furthermore, rising pharmaceutical and biotechnology R&D spending and government financing for omics are expected to boost the market growth.

The availability of research funds and the demand for high-throughput technology are likely to increase due to increased research activity. 

This market's growth is expected to be limited by high capital investment needs and data management concerns. In addition, high research expenditure, high failure rates, and obstacles with pharmaceutical distribution are all issues restricting this industry's growth. However, because of the increased interest in biotechnology and pharmaceuticals, RNA-based treatments have the potential to thrive despite the constraints.

Creating libraries for mRNA sequencing is a time-consuming and often error-prone procedure that involves multiple processes and sample loss at each step.

Reproducibility can be hampered by a lack of consistency between sequencing platforms and read depth, equal to the percentage of total transcripts sequenced. Although RNA-seq has gotten more inexpensive, it is still out of reach for many scientists.

This research report on the Middle East & Africa RNA Analysis Market has been segmented and sub-segmented into the following categories.

By End User:

  • Academic Research & Government Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Centres

By Type:

  • Microarrays
    • Reagents
    • Instruments
    • Software
  • Polymerase Chain Reaction (PCR)
  • Sequencing Technologies
  • RNAi Gene Silencing

By Application:

  • Clinical Diagnosis
  • Drug Discovery
  • Toxic genomics

By Country:

  • KSA
  • UAE
  • Israel
  • the rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the MEA RNA Analysis Market is predicted to reach a decent CAGR during the forecast period.

The UAE RNA analysis market is estimated to grow significantly due to the changing lifestyles brought on by increasing prosperity; stroke, heart disease, and lung and liver cancers have replaced lower respiratory diseases and neonatal issues. 

The Saudi Arabia RNA Analysis Market is predicted to grow at a significant rate owing to the result of an increase in infectious disease cases, as well as a changing environment due to pollution and other factors. 

The South African RNA Analysis Market is being pushed by the increased occurrence of such diseases and the demand for better therapies. In addition, infections with COVID-19 are on the rise in the Middle East and Africa.

KEY MARKET PLAYERS

Key Market Companies leading the Middle East & Africa RNA Analysis Market Profiled in the Report are Illumina Inc, F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Bio-Rad Laboratories Inc, GE Healthcare,Sigma Aldrich, Fluidigm Corporation, Qiagen N.V, Affymetrix Inc, and Thermofisher Scientific Inc.,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample